This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WEX To Serve As Presenting Sponsor Of Maine Cancer Foundation’s Tri For A Cure For 2013, 2014 And 2015

WEX Inc. (NYSE: WXS), a leading international provider of physical, digital and virtual corporate card payment solutions, today announced that it will serve as the Presenting Sponsor of the Tri for a Cure event for Maine Cancer Foundation (MCF), a statewide source of cancer grant funding, from 2013 to 2015. At the invitation of MCF executive director, Tara Hill, WEX chairman, president and CEO, Michael E. Dubyak, delivered opening remarks to a group of more than 250 business leaders at the Portland Regional Chamber of Commerce breakfast on December 5 announcing the three year gift.

“Maine Cancer Foundation is deeply committed to cancer research, education and patient support ― and WEX is deeply committed to its mission to find a cure and to support the people of Maine who find themselves affected by this disease,” said Dubyak. “It was our honor and our privilege to serve as the MCF Tri for a Cure Presenting Sponsor in 2012, a record-breaking event that raised $1,200,000. We made the decision to sponsor the Tri for a Cure for the next three years for many reasons including the fact that 100% of funds raised by Maine Cancer Foundation stay in Maine and are reinvested back in our community.”

“We are deeply appreciative of all that WEX has done for MCF and the Maine community and we look forward to making an even greater impact together through the Tri for a Cure event over the next three years,” said Tara Hill, executive director of MCF. “Investing in organizations like MCF is a triple-win for the business community in that it provides outlets for community involvement, actively attracts talent and federal money to the state, and it has a serious and lasting effect on medical research for cancer ― the No. 1 cause of death in our state.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,751.39 +121.12 0.69%
S&P 500 2,108.38 +15.13 0.72%
NASDAQ 5,111.7330 +22.5270 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs